Appendix B: Panel Roster and Financial Disclosures
Section Review Group
| Member | Institution | Financial Disclosure | |
|---|---|---|---|
| Company | Relationship | ||
| Lydia Barakat | Yale University School of Medicine | None | N/A |
| Thomas Campbell* | University of Colorado Denver School of Medicine | None | N/A |
| Ellen Kitchell | University of Texas Southwestern Medical School | None | N/A |
| Susana Lazarte | The University of Texas Southwestern Medical Center | Gilead Sciences | Research Support (paid to institution) |
| Rodrigo Mauricio Burgos | University of Illinois Chicago College of Pharmacy | OptumRx | Consultant |
| Merck Janssen Vaccines & Prevention B.V. ModernaTX, Inc. |
Research Support (paid to institution) | ||
| Paul Pham | Johns Hopkins University School of Medicine; Westview Urgent Care Medi Center | Gilead Sciences AbbVie |
Equity interest |
| Gregory Robbins | Massachusetts General Hospital | AIDS Clinical Trial Group Leonard Meron Biosciences Gilead Sciences Emergent Biosolutions Biotech USA, Inc. |
Research Support (paid to institution) |
| Syneos Health | Research Support (paid to individual) | ||
| Anandi Sheth | Emory University School of Medicine | None | N/A |
| William Short | University of Pennsylvania, Perlman School of Medicine | ViiV Healthcare Gilead Sciences |
Scientific Advisory Board |
| Ronald Wilcox | Health Resources and Services Administration | None | N/A |
| * Section Group Lead Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. |
|||
Download Guidelines
- Section Only PDF (40.01 KB)
- Full Guideline PDF (6 MB)
- Tables Only PDF (928.12 KB)